James V. (Jim) Mazzo
Global President Ophthalmic Devices Carl Zeiss Meditec
How does ZEISS support leaders – both internal and external?
As the pioneers in scientific optics, ZEISS has been challenging the limits of human imagination for a long time. We support leaders through our passion for excellence and pursuit of scientific advancement, while being in close proximity with our customers and the leaders in science and medicine today. This symbiosis is simply a part of our DNA. Following our founder Carl Zeiss’ entrepreneurial footsteps, we seek to recruit and to partner with the top minds of today, and promote the education of scientists and developers of tomorrow – our future leaders. The ZEISS Group is owned by the Carl Zeiss Foundation which promotes and supports science and education for the benefit of mankind. Both, ZEISS and the Foundation, support leading academic, scientific and cultural institutions in a variety of ways from fellowships, to our active involvement with global and regional associations.
What does it take for a company like ZEISS to rise to a position of influence within eyecare?
Innovation is deeply rooted in our history. We’ve been able to introduce many industry-first solutions like surgical microscopes, OCT and trifocal IOLs through close collaboration with our customers. We believe this cross-sectoral exchange of ideas promotes progress in medicine and development of new technologies and innovative products.
Our company is characterized by the partnership between industry and science. We work closely with clinicians who bring years of experience and clinical leadership as doctors in private practice, or in hospitals. In technology development, we collaborate with leading universities and research institutes. Together, our goal is to achieve best possible outcomes for patients and to develop market-shaping solutions that advance ophthalmic care.
How does ZEISS plan to continue leading the field – and making a difference to ophthalmologists and patients – in the coming years?
Ophthalmology and optometry are rapidly evolving. Digital technology is fundamentally changing our world and majorly impacting the healthcare industry. Doctors are working under entirely different conditions, especially with increases in patient demand, treatment options, patient access to information, and cost pressure. Thus, we will continue to expand our portfolio with solutions that address these challenges with a focus on digital solutions tailored to help doctors achieve better patient outcomes while streamlining workflows at the same time. If we consistently live up to this, we are confident that our business will continue to grow.
www.zeiss.com
